- call +1-201-465-4211
- email sales@mrinsights.biz
According to this latest study, the 2021 growth of Pharmaceutical Regulatory Affairs will have significant change from previous year. By the most conservative estimates of global Pharmaceutical Regulatory Affairs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Pharmaceutical Regulatory Affairs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Regulatory Affairs market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Regulatory Consulting
Legal Representation
Regulatory Writing & Publishing
Product Registration & Clinical Trial Application
Other Services
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
In-house
Outsourcing
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
QuintilesIMS
LabCor
PAREXEL
Pharmaceutical Product Development
INC RESEARCH HOLDINGS
PRA Health Sciences
ICON
Charles River
Advent International
WuXi AppTec, Inc.
Pharmaron Beijing Co., Ltd.
Hangzhou Tigermed Consulting Co.,Ltd.
Asymchem Laboratories (Tianjin) Co.,Ltd.
Accell Clinical Research, LLC.
GenPact Ltd.
Criterium, Inc.
Promedica International
Medpace
Covance
Freyr
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pharmaceutical Regulatory Affairs Market Size 2016-2026
2.1.2 Pharmaceutical Regulatory Affairs Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Pharmaceutical Regulatory Affairs Segment by Type
2.2.1 Regulatory Consulting
2.2.2 Regulatory Consulting
2.2.3 Regulatory Writing & Publishing
2.2.4 Product Registration & Clinical Trial Application
2.2.5 Other Services
2.3 Pharmaceutical Regulatory Affairs Market Size by Type
2.3.1 Global Pharmaceutical Regulatory Affairs Market Size CAGR by Type
2.3.2 Global Pharmaceutical Regulatory Affairs Market Size Market Share by Type (2016-2021)
2.4 Pharmaceutical Regulatory Affairs Segment by Application
2.4.1 In-house
2.4.2 Outsourcing
2.5 Pharmaceutical Regulatory Affairs Market Size by Application
2.5.1 Global Pharmaceutical Regulatory Affairs Market Size CAGR by Application
2.5.2 Global Pharmaceutical Regulatory Affairs Market Size Market Share by Application (2016-2021)
3 Pharmaceutical Regulatory Affairs Market Size by Players
3.1 Pharmaceutical Regulatory Affairs Market Size Market Share by Players
3.1.1 Global Pharmaceutical Regulatory Affairs Revenue by Players (2019-2021E)
3.1.2 Global Pharmaceutical Regulatory Affairs Revenue Market Share by Players (2019-2021E)
3.2 Global Pharmaceutical Regulatory Affairs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Pharmaceutical Regulatory Affairs by Regions
4.1 Pharmaceutical Regulatory Affairs Market Size by Regions (2016-2021)
4.2 Americas Pharmaceutical Regulatory Affairs Market Size Growth (2016-2021)
4.3 APAC Pharmaceutical Regulatory Affairs Market Size Growth (2016-2021)
4.4 Europe Pharmaceutical Regulatory Affairs Market Size Growth (2016-2021)
4.5 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size Growth (2016-2021)
5 Americas
5.1 Americas Pharmaceutical Regulatory Affairs Market Size by Country (2016-2021)
5.2 Americas Pharmaceutical Regulatory Affairs Market Size by Type (2016-2021)
5.3 Americas Pharmaceutical Regulatory Affairs Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Regulatory Affairs Market Size by Region (2016-2021)
6.2 APAC Pharmaceutical Regulatory Affairs Market Size by Type (2016-2021)
6.3 APAC Pharmaceutical Regulatory Affairs Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Pharmaceutical Regulatory Affairs by Country (2016-2021)
7.2 Europe Pharmaceutical Regulatory Affairs Market Size by Type (2016-2021)
7.3 Europe Pharmaceutical Regulatory Affairs Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pharmaceutical Regulatory Affairs by Region (2016-2021)
8.2 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Type (2016-2021)
8.3 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Pharmaceutical Regulatory Affairs Market Forecast
10.1 Global Pharmaceutical Regulatory Affairs Forecast by Regions (2021-2026)
10.1.1 Global Pharmaceutical Regulatory Affairs Forecast by Regions (2021-2026)
10.1.2 Americas Pharmaceutical Regulatory Affairs Forecast
10.1.3 APAC Pharmaceutical Regulatory Affairs Forecast
10.1.4 Europe Pharmaceutical Regulatory Affairs Forecast
10.1.5 Middle East & Africa Pharmaceutical Regulatory Affairs Forecast
10.2 Americas Pharmaceutical Regulatory Affairs Forecast by Countries (2021-2026)
10.2.1 United States Pharmaceutical Regulatory Affairs Market Forecast
10.2.2 Canada Pharmaceutical Regulatory Affairs Market Forecast
10.2.3 Mexico Pharmaceutical Regulatory Affairs Market Forecast
10.2.4 Brazil Pharmaceutical Regulatory Affairs Market Forecast
10.3 APAC Pharmaceutical Regulatory Affairs Forecast by Region (2021-2026)
10.3.1 China Pharmaceutical Regulatory Affairs Market Forecast
10.3.2 Japan Pharmaceutical Regulatory Affairs Market Forecast
10.3.3 Korea Pharmaceutical Regulatory Affairs Market Forecast
10.3.4 Southeast Asia Pharmaceutical Regulatory Affairs Market Forecast
10.3.5 India Pharmaceutical Regulatory Affairs Market Forecast
10.3.6 Australia Pharmaceutical Regulatory Affairs Market Forecast
10.4 Europe Pharmaceutical Regulatory Affairs Forecast by Country (2021-2026)
10.4.1 Germany Pharmaceutical Regulatory Affairs Market Forecast
10.4.2 France Pharmaceutical Regulatory Affairs Market Forecast
10.4.3 UK Pharmaceutical Regulatory Affairs Market Forecast
10.4.4 Italy Pharmaceutical Regulatory Affairs Market Forecast
10.4.5 Russia Pharmaceutical Regulatory Affairs Market Forecast
10.5 Middle East & Africa Pharmaceutical Regulatory Affairs Forecast by Region (2021-2026)
10.5.1 Egypt Pharmaceutical Regulatory Affairs Market Forecast
10.5.2 South Africa Pharmaceutical Regulatory Affairs Market Forecast
10.5.3 Israel Pharmaceutical Regulatory Affairs Market Forecast
10.5.4 Turkey Pharmaceutical Regulatory Affairs Market Forecast
10.5.5 GCC Countries Pharmaceutical Regulatory Affairs Market Forecast
10.6 Global Pharmaceutical Regulatory Affairs Forecast by Type (2021-2026)
10.8 Global Pharmaceutical Regulatory Affairs Forecast by Application (2021-2026)
11 Key Players Analysis
11.1 QuintilesIMS
11.1.1 QuintilesIMS Company Information
11.1.2 QuintilesIMS Pharmaceutical Regulatory Affairs Product Offered
11.1.3 QuintilesIMS Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 QuintilesIMS Main Business Overview
11.1.5 QuintilesIMS Latest Developments
11.2 LabCor
11.2.1 LabCor Company Information
11.2.2 LabCor Pharmaceutical Regulatory Affairs Product Offered
11.2.3 LabCor Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 LabCor Main Business Overview
11.2.5 LabCor Latest Developments
11.3 PAREXEL
11.3.1 PAREXEL Company Information
11.3.2 PAREXEL Pharmaceutical Regulatory Affairs Product Offered
11.3.3 PAREXEL Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 PAREXEL Main Business Overview
11.3.5 PAREXEL Latest Developments
11.4 Pharmaceutical Product Development
11.4.1 Pharmaceutical Product Development Company Information
11.4.2 Pharmaceutical Product Development Pharmaceutical Regulatory Affairs Product Offered
11.4.3 Pharmaceutical Product Development Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Pharmaceutical Product Development Main Business Overview
11.4.5 Pharmaceutical Product Development Latest Developments
11.5 INC RESEARCH HOLDINGS
11.5.1 INC RESEARCH HOLDINGS Company Information
11.5.2 INC RESEARCH HOLDINGS Pharmaceutical Regulatory Affairs Product Offered
11.5.3 INC RESEARCH HOLDINGS Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 INC RESEARCH HOLDINGS Main Business Overview
11.5.5 INC RESEARCH HOLDINGS Latest Developments
11.6 PRA Health Sciences
11.6.1 PRA Health Sciences Company Information
11.6.2 PRA Health Sciences Pharmaceutical Regulatory Affairs Product Offered
11.6.3 PRA Health Sciences Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 PRA Health Sciences Main Business Overview
11.6.5 PRA Health Sciences Latest Developments
11.7 ICON
11.7.1 ICON Company Information
11.7.2 ICON Pharmaceutical Regulatory Affairs Product Offered
11.7.3 ICON Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 ICON Main Business Overview
11.7.5 ICON Latest Developments
11.8 Charles River
11.8.1 Charles River Company Information
11.8.2 Charles River Pharmaceutical Regulatory Affairs Product Offered
11.8.3 Charles River Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Charles River Main Business Overview
11.8.5 Charles River Latest Developments
11.9 Advent International
11.9.1 Advent International Company Information
11.9.2 Advent International Pharmaceutical Regulatory Affairs Product Offered
11.9.3 Advent International Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Advent International Main Business Overview
11.9.5 Advent International Latest Developments
11.10 WuXi AppTec, Inc.
11.10.1 WuXi AppTec, Inc. Company Information
11.10.2 WuXi AppTec, Inc. Pharmaceutical Regulatory Affairs Product Offered
11.10.3 WuXi AppTec, Inc. Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 WuXi AppTec, Inc. Main Business Overview
11.10.5 WuXi AppTec, Inc. Latest Developments
11. Pharmaron Beijing Co., Ltd.
11.11.1 Pharmaron Beijing Co., Ltd. Company Information
11.11.2 Pharmaron Beijing Co., Ltd. Pharmaceutical Regulatory Affairs Product Offered
11.11.3 Pharmaron Beijing Co., Ltd. Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 Pharmaron Beijing Co., Ltd. Main Business Overview
11.11.5 Pharmaron Beijing Co., Ltd. Latest Developments
11.12 Hangzhou Tigermed Consulting Co.,Ltd.
11.12.1 Hangzhou Tigermed Consulting Co.,Ltd. Company Information
11.12.2 Hangzhou Tigermed Consulting Co.,Ltd. Pharmaceutical Regulatory Affairs Product Offered
11.12.3 Hangzhou Tigermed Consulting Co.,Ltd. Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 Hangzhou Tigermed Consulting Co.,Ltd. Main Business Overview
11.12.5 Hangzhou Tigermed Consulting Co.,Ltd. Latest Developments
11.13 Asymchem Laboratories (Tianjin) Co.,Ltd.
11.13.1 Asymchem Laboratories (Tianjin) Co.,Ltd. Company Information
11.13.2 Asymchem Laboratories (Tianjin) Co.,Ltd. Pharmaceutical Regulatory Affairs Product Offered
11.13.3 Asymchem Laboratories (Tianjin) Co.,Ltd. Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 Asymchem Laboratories (Tianjin) Co.,Ltd. Main Business Overview
11.13.5 Asymchem Laboratories (Tianjin) Co.,Ltd. Latest Developments
11.14 Accell Clinical Research, LLC.
11.14.1 Accell Clinical Research, LLC. Company Information
11.14.2 Accell Clinical Research, LLC. Pharmaceutical Regulatory Affairs Product Offered
11.14.3 Accell Clinical Research, LLC. Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2019-2021)
11.14.4 Accell Clinical Research, LLC. Main Business Overview
11.14.5 Accell Clinical Research, LLC. Latest Developments
11.15 GenPact Ltd.
11.15.1 GenPact Ltd. Company Information
11.15.2 GenPact Ltd. Pharmaceutical Regulatory Affairs Product Offered
11.15.3 GenPact Ltd. Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2019-2021)
11.15.4 GenPact Ltd. Main Business Overview
11.15.5 GenPact Ltd. Latest Developments
11.16 Criterium, Inc.
11.16.1 Criterium, Inc. Company Information
11.16.2 Criterium, Inc. Pharmaceutical Regulatory Affairs Product Offered
11.16.3 Criterium, Inc. Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2019-2021)
11.16.4 Criterium, Inc. Main Business Overview
11.16.5 Criterium, Inc. Latest Developments
11.17 Promedica International
11.17.1 Promedica International Company Information
11.17.2 Promedica International Pharmaceutical Regulatory Affairs Product Offered
11.17.3 Promedica International Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2019-2021)
11.17.4 Promedica International Main Business Overview
11.17.5 Promedica International Latest Developments
11.18 Medpace
11.18.1 Medpace Company Information
11.18.2 Medpace Pharmaceutical Regulatory Affairs Product Offered
11.18.3 Medpace Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2019-2021)
11.18.4 Medpace Main Business Overview
11.18.5 Medpace Latest Developments
11.19 Covance
11.19.1 Covance Company Information
11.19.2 Covance Pharmaceutical Regulatory Affairs Product Offered
11.19.3 Covance Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2019-2021)
11.19.4 Covance Main Business Overview
11.19.5 Covance Latest Developments
11.20 Freyr
11.20.1 Freyr Company Information
11.20.2 Freyr Pharmaceutical Regulatory Affairs Product Offered
11.20.3 Freyr Pharmaceutical Regulatory Affairs Revenue, Gross Margin and Market Share (2019-2021)
11.20.4 Freyr Main Business Overview
11.20.5 Freyr Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Pharmaceutical Regulatory Affairs Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Regulatory Consulting
Table 3. Major Players of Legal Representation
Table 4. Major Players of Regulatory Writing & Publishing
Table 5. Major Players of Product Registration & Clinical Trial Application
Table 6. Major Players of Other Services
Table 7. Pharmaceutical Regulatory Affairs Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 8. Global Pharmaceutical Regulatory Affairs Market Size by Type (2016-2021) & ($ Millions)
Table 9. Global Pharmaceutical Regulatory Affairs Market Size Market Share by Type (2016-2021)
Table 10. Pharmaceutical Regulatory Affairs Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 11. Global Pharmaceutical Regulatory Affairs Market Size by Application (2016-2021) & ($ Millions)
Table 12. Global Pharmaceutical Regulatory Affairs Market Size Market Share by Application (2016-2021)
Table 13. Global Pharmaceutical Regulatory Affairs Revenue by Players (2019-2021E) & ($ Millions)
Table 14. Global Pharmaceutical Regulatory Affairs Revenue Market Share by Players (2019-2021E)
Table 15. Pharmaceutical Regulatory Affairs Key Players Head office and Products Offered
Table 16. Pharmaceutical Regulatory Affairs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Pharmaceutical Regulatory Affairs Market Size by Regions 2016-2021 & ($ Millions)
Table 20. Global Pharmaceutical Regulatory Affairs Market Size Market Share by Regions 2016-2021
Table 21. Americas Pharmaceutical Regulatory Affairs Market Size by Country (2016-2021) & ($ Millions)
Table 22. Americas Pharmaceutical Regulatory Affairs Market Size Market Share by Country (2016-2021)
Table 23. Americas Pharmaceutical Regulatory Affairs Market Size by Type (2016-2021) & ($ Millions)
Table 24. Americas Pharmaceutical Regulatory Affairs Market Size Market Share by Type (2016-2021)
Table 25. Americas Pharmaceutical Regulatory Affairs Market Size by Application (2016-2021) & ($ Millions)
Table 26. Americas Pharmaceutical Regulatory Affairs Market Size Market Share by Application (2016-2021)
Table 27. APAC Pharmaceutical Regulatory Affairs Market Size by Region (2016-2021) & ($ Millions)
Table 28. APAC Pharmaceutical Regulatory Affairs Market Size Market Share by Region (2016-2021)
Table 29. APAC Pharmaceutical Regulatory Affairs Market Size by Type (2016-2021) & ($ Millions)
Table 30. APAC Pharmaceutical Regulatory Affairs Market Size Market Share by Type (2016-2021)
Table 31. APAC Pharmaceutical Regulatory Affairs Market Size by Application (2016-2021) & ($ Millions)
Table 32. APAC Pharmaceutical Regulatory Affairs Market Size Market Share by Application (2016-2021)
Table 33. Europe Pharmaceutical Regulatory Affairs Market Size by Country (2016-2021) & ($ Millions)
Table 34. Europe Pharmaceutical Regulatory Affairs Market Size Market Share by Country (2016-2021)
Table 35. Europe Pharmaceutical Regulatory Affairs Market Size by Type (2016-2021) & ($ Millions)
Table 36. Europe Pharmaceutical Regulatory Affairs Market Size Market Share by Type (2016-2021)
Table 37. Europe Pharmaceutical Regulatory Affairs Market Size by Application (2016-2021) & ($ Millions)
Table 38. Europe Pharmaceutical Regulatory Affairs Market Size Market Share by Application (2016-2021)
Table 39. Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Region (2016-2021) & ($ Millions)
Table 40. Middle East & Africa Pharmaceutical Regulatory Affairs Market Size Market Share by Region (2016-2021)
Table 41. Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Type (2016-2021) & ($ Millions)
Table 42. Middle East & Africa Pharmaceutical Regulatory Affairs Market Size Market Share by Type (2016-2021)
Table 43. Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Application (2016-2021) & ($ Millions)
Table 44. Middle East & Africa Pharmaceutical Regulatory Affairs Market Size Market Share by Application (2016-2021)
Table 45. Key and Potential Regions of Pharmaceutical Regulatory Affairs
Table 46. Key Application and Potential Industries of Pharmaceutical Regulatory Affairs
Table 47. Key Challenges of Pharmaceutical Regulatory Affairs
Table 48. Key Trends of Pharmaceutical Regulatory Affairs
Table 49. Global Pharmaceutical Regulatory Affairs Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 50. Global Pharmaceutical Regulatory Affairs Market Size Market Share Forecast by Regions (2021-2026)
Table 51. Global Pharmaceutical Regulatory Affairs Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 52. Global Pharmaceutical Regulatory Affairs Market Size Market Share Forecast by Type (2021-2026)
Table 53. Global Pharmaceutical Regulatory Affairs Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 54. Global Pharmaceutical Regulatory Affairs Market Size Market Share Forecast by Application (2021-2026)
Table 55. QuintilesIMS Details, Company Type, Pharmaceutical Regulatory Affairs Area Served and Its Competitors
Table 56. QuintilesIMS Pharmaceutical Regulatory Affairs Product Offered
Table 57. QuintilesIMS Pharmaceutical Regulatory Affairs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 58. QuintilesIMS Main Business
Table 59. QuintilesIMS Latest Developments
Table 60. LabCor Details, Company Type, Pharmaceutical Regulatory Affairs Area Served and Its Competitors
Table 61. LabCor Pharmaceutical Regulatory Affairs Product Offered
Table 62. LabCor Main Business
Table 63. LabCor Pharmaceutical Regulatory Affairs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 64. LabCor Latest Developments
Table 65. PAREXEL Details, Company Type, Pharmaceutical Regulatory Affairs Area Served and Its Competitors
Table 66. PAREXEL Pharmaceutical Regulatory Affairs Product Offered
Table 67. PAREXEL Main Business
Table 68. PAREXEL Pharmaceutical Regulatory Affairs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 69. PAREXEL Latest Developments
Table 70. Pharmaceutical Product Development Details, Company Type, Pharmaceutical Regulatory Affairs Area Served and Its Competitors
Table 71. Pharmaceutical Product Development Pharmaceutical Regulatory Affairs Product Offered
Table 72. Pharmaceutical Product Development Main Business
Table 73. Pharmaceutical Product Development Pharmaceutical Regulatory Affairs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 74. Pharmaceutical Product Development Latest Developments
Table 75. INC RESEARCH HOLDINGS Details, Company Type, Pharmaceutical Regulatory Affairs Area Served and Its Competitors
Table 76. INC RESEARCH HOLDINGS Pharmaceutical Regulatory Affairs Product Offered
Table 77. INC RESEARCH HOLDINGS Main Business
Table 78. INC RESEARCH HOLDINGS Pharmaceutical Regulatory Affairs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 79. INC RESEARCH HOLDINGS Latest Developments
Table 80. PRA Health Sciences Details, Company Type, Pharmaceutical Regulatory Affairs Area Served and Its Competitors
Table 81. PRA Health Sciences Pharmaceutical Regulatory Affairs Product Offered
Table 82. PRA Health Sciences Main Business
Table 83. PRA Health Sciences Pharmaceutical Regulatory Affairs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 84. PRA Health Sciences Latest Developments
Table 85. ICON Details, Company Type, Pharmaceutical Regulatory Affairs Area Served and Its Competitors
Table 86. ICON Pharmaceutical Regulatory Affairs Product Offered
Table 87. ICON Main Business
Table 88. ICON Pharmaceutical Regulatory Affairs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 89. ICON Latest Developments
Table 90. Charles River Details, Company Type, Pharmaceutical Regulatory Affairs Area Served and Its Competitors
Table 91. Charles River Pharmaceutical Regulatory Affairs Product Offered
Table 92. Charles River Main Business
Table 93. Charles River Pharmaceutical Regulatory Affairs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 94. Charles River Latest Developments
Table 95. Advent International Details, Company Type, Pharmaceutical Regulatory Affairs Area Served and Its Competitors
Table 96. Advent International Pharmaceutical Regulatory Affairs Product Offered
Table 97. Advent International Main Business
Table 98. Advent International Pharmaceutical Regulatory Affairs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 99. Advent International Latest Developments
Table 100. WuXi AppTec, Inc. Details, Company Type, Pharmaceutical Regulatory Affairs Area Served and Its Competitors
Table 101. WuXi AppTec, Inc. Pharmaceutical Regulatory Affairs Product Offered
Table 102. WuXi AppTec, Inc. Main Business
Table 103. WuXi AppTec, Inc. Pharmaceutical Regulatory Affairs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 104. WuXi AppTec, Inc. Latest Developments
Table 105. Pharmaron Beijing Co., Ltd. Details, Company Type, Pharmaceutical Regulatory Affairs Area Served and Its Competitors
Table 106. Pharmaron Beijing Co., Ltd. Pharmaceutical Regulatory Affairs Product Offered
Table 107. Pharmaron Beijing Co., Ltd. Pharmaceutical Regulatory Affairs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 108. Pharmaron Beijing Co., Ltd. Main Business
Table 109. Pharmaron Beijing Co., Ltd. Latest Developments
Table 110. Hangzhou Tigermed Consulting Co.,Ltd. Details, Company Type, Pharmaceutical Regulatory Affairs Area Served and Its Competitors
Table 111. Hangzhou Tigermed Consulting Co.,Ltd. Pharmaceutical Regulatory Affairs Product Offered
Table 112. Hangzhou Tigermed Consulting Co.,Ltd. Main Business
Table 113. Hangzhou Tigermed Consulting Co.,Ltd. Pharmaceutical Regulatory Affairs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 114. Hangzhou Tigermed Consulting Co.,Ltd. Latest Developments
Table 115. Asymchem Laboratories (Tianjin) Co.,Ltd. Details, Company Type, Pharmaceutical Regulatory Affairs Area Served and Its Competitors
Table 116. Asymchem Laboratories (Tianjin) Co.,Ltd. Pharmaceutical Regulatory Affairs Product Offered
Table 117. Asymchem Laboratories (Tianjin) Co.,Ltd. Main Business
Table 118. Asymchem Laboratories (Tianjin) Co.,Ltd. Pharmaceutical Regulatory Affairs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 119. Asymchem Laboratories (Tianjin) Co.,Ltd. Latest Developments
Table 120. Accell Clinical Research, LLC. Details, Company Type, Pharmaceutical Regulatory Affairs Area Served and Its Competitors
Table 121. Accell Clinical Research, LLC. Pharmaceutical Regulatory Affairs Product Offered
Table 122. Accell Clinical Research, LLC. Main Business
Table 123. Accell Clinical Research, LLC. Pharmaceutical Regulatory Affairs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 124. Accell Clinical Research, LLC. Latest Developments
Table 125. GenPact Ltd. Details, Company Type, Pharmaceutical Regulatory Affairs Area Served and Its Competitors
Table 126. GenPact Ltd. Pharmaceutical Regulatory Affairs Product Offered
Table 127. GenPact Ltd. Main Business
Table 128. GenPact Ltd. Pharmaceutical Regulatory Affairs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 129. GenPact Ltd. Latest Developments
Table 130. Criterium, Inc. Details, Company Type, Pharmaceutical Regulatory Affairs Area Served and Its Competitors
Table 131. Criterium, Inc. Pharmaceutical Regulatory Affairs Product Offered
Table 132. Criterium, Inc. Main Business
Table 133. Criterium, Inc. Pharmaceutical Regulatory Affairs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 134. Criterium, Inc. Latest Developments
Table 135. Promedica International Details, Company Type, Pharmaceutical Regulatory Affairs Area Served and Its Competitors
Table 136. Promedica International Pharmaceutical Regulatory Affairs Product Offered
Table 137. Promedica International Main Business
Table 138. Promedica International Pharmaceutical Regulatory Affairs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 139. Promedica International Latest Developments
Table 140. Medpace Details, Company Type, Pharmaceutical Regulatory Affairs Area Served and Its Competitors
Table 141. Medpace Pharmaceutical Regulatory Affairs Product Offered
Table 142. Medpace Main Business
Table 143. Medpace Pharmaceutical Regulatory Affairs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 144. Medpace Latest Developments
Table 145. Covance Details, Company Type, Pharmaceutical Regulatory Affairs Area Served and Its Competitors
Table 146. Covance Pharmaceutical Regulatory Affairs Product Offered
Table 147. Covance Main Business
Table 148. Covance Pharmaceutical Regulatory Affairs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 149. Covance Latest Developments
Table 150. Freyr Details, Company Type, Pharmaceutical Regulatory Affairs Area Served and Its Competitors
Table 151. Freyr Pharmaceutical Regulatory Affairs Product Offered
Table 152. Freyr Main Business
Table 153. Freyr Pharmaceutical Regulatory Affairs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 154. Freyr Latest Developments
List of Figures
Figure 1. Pharmaceutical Regulatory Affairs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Pharmaceutical Regulatory Affairs Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Pharmaceutical Regulatory Affairs Market Size Market Share by Type in 2020
Figure 7. Pharmaceutical Regulatory Affairs in In-house
Figure 8. Global Pharmaceutical Regulatory Affairs Market: In-house (2016-2021) & ($ Millions)
Figure 9. Pharmaceutical Regulatory Affairs in Outsourcing
Figure 10. Global Pharmaceutical Regulatory Affairs Market: Outsourcing (2016-2021) & ($ Millions)
Figure 11. Global Pharmaceutical Regulatory Affairs Market Size Market Share by Application in 2020
Figure 12. Global Pharmaceutical Regulatory Affairs Revenue Market Share by Player in 2020
Figure 13. Global Pharmaceutical Regulatory Affairs Market Size Market Share by Regions (2016-2021)
Figure 14. Americas Pharmaceutical Regulatory Affairs Market Size 2016-2021 ($ Millions)
Figure 15. APAC Pharmaceutical Regulatory Affairs Market Size 2016-2021 ($ Millions)
Figure 16. Europe Pharmaceutical Regulatory Affairs Market Size 2016-2021 ($ Millions)
Figure 17. Middle East & Africa Pharmaceutical Regulatory Affairs Market Size 2016-2021 ($ Millions)
Figure 18. Americas Pharmaceutical Regulatory Affairs Market Size Market Share by Country in 2020
Figure 19. Americas Pharmaceutical Regulatory Affairs Market Size Market Share by Type in 2020
Figure 20. Americas Pharmaceutical Regulatory Affairs Market Size Market Share by Application in 2020
Figure 21. United States Pharmaceutical Regulatory Affairs Market Size Growth 2016-2021 ($ Millions)
Figure 22. Canada Pharmaceutical Regulatory Affairs Market Size Growth 2016-2021 ($ Millions)
Figure 23. Mexico Pharmaceutical Regulatory Affairs Market Size Growth 2016-2021 ($ Millions)
Figure 24. APAC Pharmaceutical Regulatory Affairs Market Size Market Share by Regions in 2020
Figure 25. APAC Pharmaceutical Regulatory Affairs Market Size Market Share by Type in 2020
Figure 26. APAC Pharmaceutical Regulatory Affairs Market Size Market Share by Application in 2020
Figure 27. China Pharmaceutical Regulatory Affairs Market Size Growth 2016-2021 ($ Millions)
Figure 28. Japan Pharmaceutical Regulatory Affairs Market Size Growth 2016-2021 ($ Millions)
Figure 29. Korea Pharmaceutical Regulatory Affairs Market Size Growth 2016-2021 ($ Millions)
Figure 30. Southeast Asia Pharmaceutical Regulatory Affairs Market Size Growth 2016-2021 ($ Millions)
Figure 31. India Pharmaceutical Regulatory Affairs Market Size Growth 2016-2021 ($ Millions)
Figure 32. Australia Pharmaceutical Regulatory Affairs Market Size Growth 2016-2021 ($ Millions)
Figure 33. Europe Pharmaceutical Regulatory Affairs Market Size Market Share by Country in 2020
Figure 34. Europe Pharmaceutical Regulatory Affairs Market Size Market Share by Type in 2020
Figure 35. Europe Pharmaceutical Regulatory Affairs Market Size Market Share by Application in 2020
Figure 36. Germany Pharmaceutical Regulatory Affairs Market Size Growth 2016-2021 ($ Millions)
Figure 37. France Pharmaceutical Regulatory Affairs Market Size Growth 2016-2021 ($ Millions)
Figure 38. UK Pharmaceutical Regulatory Affairs Market Size Growth 2016-2021 ($ Millions)
Figure 39. Italy Pharmaceutical Regulatory Affairs Market Size Growth 2016-2021 ($ Millions)
Figure 40. Russia Pharmaceutical Regulatory Affairs Market Size Growth 2016-2021 ($ Millions)
Figure 41. Middle East & Africa Pharmaceutical Regulatory Affairs Market Size Market Share by Region in 2020
Figure 42. Middle East & Africa Pharmaceutical Regulatory Affairs Market Size Market Share by Type in 2020
Figure 43. Middle East & Africa Pharmaceutical Regulatory Affairs Market Size Market Share by Application in 2020
Figure 44. Egypt Pharmaceutical Regulatory Affairs Market Size Growth 2016-2021 ($ Millions)
Figure 45. South Africa Pharmaceutical Regulatory Affairs Market Size Growth 2016-2021 ($ Millions)
Figure 46. Israel Pharmaceutical Regulatory Affairs Market Size Growth 2016-2021 ($ Millions)
Figure 47. Turkey Pharmaceutical Regulatory Affairs Market Size Growth 2016-2021 ($ Millions)
Figure 48. GCC Country Pharmaceutical Regulatory Affairs Market Size Growth 2016-2021 ($ Millions)
Figure 49. Americas Pharmaceutical Regulatory Affairs Market Size 2021-2026 ($ Millions)
Figure 50. APAC Pharmaceutical Regulatory Affairs Market Size 2021-2026 ($ Millions)
Figure 51. Europe Pharmaceutical Regulatory Affairs Market Size 2021-2026 ($ Millions)
Figure 52. Middle East & Africa Pharmaceutical Regulatory Affairs Market Size 2021-2026 ($ Millions)
Figure 53. United States Pharmaceutical Regulatory Affairs Market Size 2021-2026 ($ Millions)
Figure 54. Canada Pharmaceutical Regulatory Affairs Market Size 2021-2026 ($ Millions)
Figure 55. Mexico Pharmaceutical Regulatory Affairs Market Size 2021-2026 ($ Millions)
Figure 56. Brazil Pharmaceutical Regulatory Affairs Market Size 2021-2026 ($ Millions)
Figure 57. China Pharmaceutical Regulatory Affairs Market Size 2021-2026 ($ Millions)
Figure 58. Japan Pharmaceutical Regulatory Affairs Market Size 2021-2026 ($ Millions)
Figure 59. Korea Pharmaceutical Regulatory Affairs Market Size 2021-2026 ($ Millions)
Figure 60. Southeast Asia Pharmaceutical Regulatory Affairs Market Size 2021-2026 ($ Millions)
Figure 61. India Pharmaceutical Regulatory Affairs Market Size 2021-2026 ($ Millions)
Figure 62. Australia Pharmaceutical Regulatory Affairs Market Size 2021-2026 ($ Millions)
Figure 63. Germany Pharmaceutical Regulatory Affairs Market Size 2021-2026 ($ Millions)
Figure 64. France Pharmaceutical Regulatory Affairs Market Size 2021-2026 ($ Millions)
Figure 65. UK Pharmaceutical Regulatory Affairs Market Size 2021-2026 ($ Millions)
Figure 66. Italy Pharmaceutical Regulatory Affairs Market Size 2021-2026 ($ Millions)
Figure 67. Russia Pharmaceutical Regulatory Affairs Market Size 2021-2026 ($ Millions)
Figure 68. Spain Pharmaceutical Regulatory Affairs Market Size 2021-2026 ($ Millions)
Figure 69. Egypt Pharmaceutical Regulatory Affairs Market Size 2021-2026 ($ Millions)
Figure 70. South Africa Pharmaceutical Regulatory Affairs Market Size 2021-2026 ($ Millions)
Figure 71. Israel Pharmaceutical Regulatory Affairs Market Size 2021-2026 ($ Millions)
Figure 72. Turkey Pharmaceutical Regulatory Affairs Market Size 2021-2026 ($ Millions)
Figure 73. GCC Country Pharmaceutical Regulatory Affairs Market Size 2021-2026 ($ Millions)
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
